Safety of Volume Replacement with HES 130/0.4 in Cardiac Surgery with Cardiopulmonary Bypass

刘毅,朱文忠,严晓晴,张伟时,许涛,王天舒,邓小明
DOI: https://doi.org/10.3321/j.issn:0254-1416.2008.08.019
2008-01-01
Abstract:Objective To evaluate the safety of volume replacement with 6% hydroxyethyl starch (HES) 130/0.4 in cardiac, surgery with eardiopulmonary bypass (CPB). Methods Sixty ASA Ⅱ orⅢ patients aged 18-64 yr undergoing cardiac surgery with CPB were randomly divided into 2 groups ( n = 30 each) : group 1 6% HES 130/0.4 (HES) and groupⅡ 4% succimyl gelatin (GEL). Priming solutions contained 6% HES 130/0.4 or 4% succinyl gelatin 500-1 000 ml. 6% HES 130/0.4 and 4% suecinyl gelatin were infused at 60-120 ml/h during operation to maintain CVP at 6-12 mm Hg and/or PCWP at 8-15 mm Hg in group HES and GEL respectively. Hemodynamic parameters, Hot, blood eoagulafiun were measured before, during and after operation. Hepato-renal function was measured before and after operation. Fluid balance and adverse reactions were recorded. Results The average amount of colloid approached 50 ml·kg-1·d-1in both groups. There were no significant differences in bemodynamics, Hct, blood coagulation parameters and hepato-renal function, fluid balance and adverse reactions between the two groups. Conclusion 6% HES 130/0.4 can be safely used for plasma volume replacement in cardiac surgery with CPB if the amount is less than 50 ml·kg-1·d-1.
What problem does this paper attempt to address?